GTI Networks, Inc. develops small, implantable devices including refillable drug pump for treating cancer, heart, diabetes and other illness/syndromes. The Smart MicroPump™ can be programmed to dispense precise nanoliter-sized doses (a Lab-On-Chip biosensor gives closed-feedback) of drug to the tumor/cancer site every hour, day or month as needed metronomically over six to twenty four months before the next refill/recharge. The GTI Networks Smart MicroPump™ and Smart NanoPump™ Systems are being developed for pharmaceutical and other medical device manufacturers and FDA approval is needed before commercial distribution. See our website at www.gtinetcorp.com for more information.